Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 518a-1 (MIR518A1) is a small, non-coding RNA belonging to the miRNA class that regulates gene expression at the post-transcriptional level by binding to target messenger RNAs (mRNAs), leading to their translational repression or degradation. Like other microRNAs, MIR518A1 is first transcribed as a primary transcript (pri-miRNA), processed in the nucleus by Drosha to form a precursor miRNA (pre-miRNA), and finally cleaved in the cytoplasm by Dicer to generate the mature miRNA, which operates as part of the RNA-induced silencing complex (RISC)[1][2]. MIR518A1 has been associated with the regulation of biological processes in multicellular organisms and is implicated in several diseases, especially certain cancers and diseases of the female reproductive system[1][4]. Members of its cluster have been identified in cancer-associated microRNA panels, but there is no current evidence for direct drug interactions or therapeutic targeting[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 518a-1 (MIR518A1).